Live feed
Filing
SC 13D
SC 13D0001213900-22-080148·Immune Therapeutics, Inc.
Schedule 13D ownership disclosure
Immune Therapeutics Inc
Security class unavailable · CUSIP: 45252A107
Event date: 2022-07-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-080148
- Form type
- SC 13D
- Filer
- Immune Therapeutics, Inc.
- CIK
- CIK 1559356
- Filed
- Dec 15, 2022
- Reporting period
- Jul 25, 2022
- Description
- Schedule 13D beneficial ownership